New biosensor developed to aid early diagnosis of breast cancer
It is an easy-to-use, low-cost prototype of a nanoporous device, and provides results in less than an hourCredit: UPV A ...
It is an easy-to-use, low-cost prototype of a nanoporous device, and provides results in less than an hourCredit: UPV A ...
The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.Credit: ...
Computational approach enables analysis of meaningful data that otherwise may be lost in the noiseCredit: MD Anderson Cancer Center HOUSTON ...
Credit: Khoa Pham, M.D. Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance ...
Credit: AlphaMed Press Durham, NC -- Bone marrow failure due to acute myeloid leukemia (AML) is a significant factor behind ...
Proprietary bioinformatics, paired with comprehensive clinical curation results in reporting that defines clinically actionable, FDA-approved, and clinical trial drug options ...
Chemotherapy-free regimen results in 100% complete response rate, 85% complete molecular remission rate in newly diagnosed patientsCredit: MD Anderson Cancer ...
Drug developed by MD Anderson's Therapeutics Discovery division is well-tolerated with effective glutaminase inhibition in Phase I trialCredit: MD Anderson ...
Testing may identify patients who benefit from early HER2 targeted therapyCredit: Sanford Burnham Prebys LA JOLLA, CALIF. - May 19, ...
Credit: Huntsman Cancer Institute SALT LAKE CITY - A new study published in the Journal of Clinical Oncology reports findings ...
Study links secondhand smoke during pregnancy to epigenetic changes in babiesCredit: VCU Massey Cancer Center Nearly a quarter of pregnant ...
Credit: Angela Paschal Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act ...
The Oncotarget author's analyses of protein markers of epithelial-to-mesenchymal transition indicated that treatments with 6-mercaptopurine and/or 5-azacitidine do not significantly ...
Credit: IRB Barcelona Scientists led by Dr. Salvador Aznar-Benitah, head of the Stem Cells and Cancer laboratory at IRB Barcelona, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.